Lung Function and Sleep, Outpatient Department Area 3, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Mindelsohn Way, Edgbaston, Birmingham, B15 2GW, UK.
School of Biomedical Sciences, Institute of Clinical Sciences, University of Birmingham, Birmingham, UK.
Respir Res. 2021 Sep 27;22(1):255. doi: 10.1186/s12931-021-01834-5.
There is relatively little published on the effects of COVID-19 on respiratory physiology, particularly breathing patterns. We sought to determine if there were lasting detrimental effect following hospital discharge and if these related to the severity of COVID-19.
We reviewed lung function and breathing patterns in COVID-19 survivors > 3 months after discharge, comparing patients who had been admitted to the intensive therapy unit (ITU) (n = 47) to those who just received ward treatments (n = 45). Lung function included spirometry and gas transfer and breathing patterns were measured with structured light plethysmography. Continuous data were compared with an independent t-test or Mann Whitney-U test (depending on distribution) and nominal data were compared using a Fisher's exact test (for 2 categories in 2 groups) or a chi-squared test (for > 2 categories in 2 groups). A p-value of < 0.05 was taken to be statistically significant.
We found evidence of pulmonary restriction (reduced vital capacity and/or alveolar volume) in 65.4% of all patients. 36.1% of all patients has a reduced transfer factor (TL) but the majority of these (78.1%) had a preserved/increased transfer coefficient (K), suggesting an extrapulmonary cause. There were no major differences between ITU and ward lung function, although K alone was higher in the ITU patients (p = 0.03). This could be explained partly by obesity, respiratory muscle fatigue, localised microvascular changes, or haemosiderosis from lung damage. Abnormal breathing patterns were observed in 18.8% of subjects, although no consistent pattern of breathing pattern abnormalities was evident.
An "extrapulmonary restrictive" like pattern appears to be a common phenomenon in previously admitted COVID-19 survivors. Whilst the cause of this is not clear, the effects seem to be similar on patients whether or not they received mechanical ventilation or had ward based respiratory support/supplemental oxygen.
关于 COVID-19 对呼吸生理的影响,特别是呼吸模式,发表的文献相对较少。我们试图确定患者出院后是否存在持久的不良影响,以及这些影响是否与 COVID-19 的严重程度有关。
我们回顾了 COVID-19 幸存者出院后 3 个月以上的肺功能和呼吸模式,将入住重症监护病房(ITU)的患者(n=47)与仅接受病房治疗的患者(n=45)进行比较。肺功能包括肺活量测定和气体转移,呼吸模式通过结构光体积描记法进行测量。连续数据采用独立 t 检验或曼-惠特尼 U 检验(取决于分布)进行比较,名义数据采用 Fisher 确切检验(两组两个类别)或卡方检验(两组两个以上类别)进行比较。p 值<0.05 被认为具有统计学意义。
我们发现所有患者中 65.4%存在肺部限制(肺活量和/或肺泡容积减少)。所有患者中有 36.1%转移因子(TL)降低,但其中大多数(78.1%)转移系数(K)正常或升高,提示为肺外原因。ITU 和病房的肺功能没有明显差异,尽管 ITU 患者的 K 单独较高(p=0.03)。这部分可以用肥胖、呼吸肌疲劳、局部微血管变化或肺损伤引起的血色素沉着来解释。在 18.8%的患者中观察到异常呼吸模式,但没有明显的呼吸模式异常一致模式。
在以前住院的 COVID-19 幸存者中,似乎出现了一种“肺外限制”样模式。虽然原因尚不清楚,但无论患者是否接受机械通气或是否接受病房呼吸支持/补充氧气,这种影响似乎相似。